Literature DB >> 25579136

Know the signs and symptoms of diabetes.

A Ramachandran1.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 25579136      PMCID: PMC4311308     

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN: 0971-5916            Impact factor:   2.375


× No keyword cloud information.
Diabetes mellitus is a serious metabolic disease, affecting people of all geographic, ethnic or racial origin and its prevalence is increasing globally1. Burden from this costly disease is high on the low and middle income countries (LMIC) where the impacts of modernization and urbanization have caused marked adverse changes in lifestyle parameters. In 2013, of the estimated 382 million people with diabetes globally, more than 80 per cent lived in LMIC. It was estimated that India had 65.1 million adults with diabetes in 2013, and had the 2nd position among the top 10 countries with the largest number of diabetes. This number is predicted to increase to 109 million by 2035 unless steps are taken to prevent new cases of diabetes1. Primary prevention of diabetes is feasible and strategies such as lifestyle modification are shown to be effective in populations of varied ethnicity23. However, for implementation of the strategies at the population level, national programmes which are culturally and socially acceptable and practical have to be formulated which are currently lacking in most of the developed and developing countries. Early diagnosis and institution of appropriate therapeutic measures yield the desired glycaemic outcomes and prevent the vascular complications4. Type 2 diabetes which accounts for 85-95 per cent of all diabetes has a latent, asymptomatic period of sub-clinical stages which often remains undiagnosed for several years1. As a result, in many patients the vascular complications are already present at the time of diagnosis of diabetes, which is often detected by an opportunistic testing. Asian populations in general, particularly Asian Indians have a high risk of developing diabetes at a younger age when compared with the western populations5. Therefore, it is essential that efforts are made to diagnose diabetes early so that the long term sufferings by the patients and the societal burden can be considerably mitigated.

Risk factors for diabetes

Many studies have shown that awareness about the diabetes and its complications is poor among the general population specially in the rural areas67. There is an urgent need to create awareness among the population regarding diabetes and about the serious consequences of this chronic disorder. Epidemiological data from India have shown the presence of a number of risk factors which can be easily identified by simple non-invasive risk scores89. The major risk factors are listed in Box 1.
Box 1

Major risk factors for type 2 diabetes in Indians

Major risk factors for type 2 diabetes in Indians

Signs and symptoms of diabetes

The signs and symptoms of diabetes are disregarded by many because of the chronic progression of the disease. People do not consider this as a serious problem because unlike many other diseases the consequences of hyperglycaemia are not manifested immediately. People are not aware that damage can start several years before symptoms become noticeable. This is unfortunate because recognition of early symptoms can help to get the disease under control immediately and to prevent vascular complications.

Warning signs & classic symptoms of diabetes

Considering the asymptomatic nature of type 2 diabetes in the early stages, it is essential that the people are educated on its warning signs (Box 2).
Box 2

Warning signs of diabetes

Warning signs of diabetes The classic symptoms of diabetes such as polyuria, polydypsia and polyphagia occur commonly in type 1 diabetes, which has a rapid development of severe hyperglycaemia and also in type 2 diabetes with very high levels of hyperglycaemia. Severe weight loss is common only in type 1 diabetes or if type 2 diabetes remains undetected for a long period. Unexplained weight loss, fatigue and restlessness and body pain are also common signs of undetected diabetes. Symptoms that are mild or have gradual development could also remain unnoticed.

Screening test for diabetes

A person of Asian origin aged 35 yr or more with two or more of the above risk factors, should undergo a screening test for diabetes. An oral glucose tolerance test (OGTT) is commonly used as the screening test10. Fasting and 2 h post glucose tests can identify impaired fasting glucose (IFG) (fasting glucose >110 - <125 mg/dl), impaired glucose tolerance (IGT) (2 h glucose >140-<200 mg/dl) and presence of diabetes (fasting > 126 and 2 h glucose >200 mg/dl). If a random blood glucose value is > 150 mg/dl, further confirmation by an OGTT is warranted. Recently, glycosylated haemoglobin (HbA1c) has been recommended as the test for diagnosis of diabetes (>6.5%). Presence of pre-diabetes is indicated by HbA1c values between 5.7 - 6.4 per cent11. Screening for undiagnosed T2DM is recommended at the first prenatal visit in women with above risk factors, using standard diagnostic method criteria. Screening for gestational diabetes (GDM) at 24-28 wk of gestation is recommended in women who do not have previous history of diabetes, as GDM remains asymptomatic11. A history of GDM carries a high risk for developing diabetes.

Significance of identifying prediabetes

Even prediabetic stages such as IFG and IGT carry high risk for vascular complications such as cardiovascular diseases. The recent estimates by the International Diabetes Federation (IDF)1 indicate that globally there are more than 316 million people (6.9%) with IGT. Among them, more than 70 per cent live in LMIC1. It is also important to note that currently one third of those who have IGT are in the productive age between 20-39 yr and, therefore, are likely to spend many years at high risk of developing diabetes and/or complications of diabetes1. Some persons with prediabetes experience reactive hypoglycaemia 2-3 hours after a meal. This is a sign of impaired insulin metabolism indicative of impending occurrence of diabetes. Therefore, periodic medical check-up in people with such signs or risk factors for diabetes would reduce the hazards involved in having undiagnosed diabetes. It would help improve the health status of a large number of people who otherwise would be silent sufferers from the metabolic aberrations associated with diabetes.

Conclusions

Awareness about the signs and symptoms and periodic screening especially in the presence of risk factors and warning signs of diabetes, would go a long way in preventing new cases of diabetes by providing an opportunity to intervene at the stage of prediabetes. It is evident that diabetes can be prevented among prediabetic individuals by improvements in physical activity and diet habits. Such strategies will also prevent development of diabetic complications to a great extent. Patient empowerment is vital in diabetes management. This can be done through patient education and sharing information on management and preventive aspects of diabetes.
  10 in total

1.  Standards of medical care in diabetes--2011.

Authors: 
Journal:  Diabetes Care       Date:  2011-01       Impact factor: 19.112

Review 2.  Primary prevention of Type 2 diabetes in South Asians--challenges and the way forward.

Authors:  A Ramachandran; R Ambady; C Snehalatha; A Samith Shetty; A Nanditha
Journal:  Diabet Med       Date:  2013-01       Impact factor: 4.359

3.  Derivation and validation of diabetes risk score for urban Asian Indians.

Authors:  A Ramachandran; C Snehalatha; V Vijay; N J Wareham; S Colagiuri
Journal:  Diabetes Res Clin Pract       Date:  2005-04-15       Impact factor: 5.602

4.  Awareness about diabetes and its complications in the general and diabetic population in a city in southern India.

Authors:  N Murugesan; C Snehalatha; R Shobhana; G Roglic; A Ramachandran
Journal:  Diabetes Res Clin Pract       Date:  2007-02-08       Impact factor: 5.602

5.  Awareness and knowledge of diabetes in Chennai--the Chennai Urban Rural Epidemiology Study [CURES-9].

Authors:  Deepa Mohan; Deepa Raj; C S Shanthirani; Manjula Datta; N C Unwin; A Kapur; V Mohan
Journal:  J Assoc Physicians India       Date:  2005-04

6.  International Diabetes Federation: a consensus on Type 2 diabetes prevention.

Authors:  K G M M Alberti; P Zimmet; J Shaw
Journal:  Diabet Med       Date:  2007-05       Impact factor: 4.359

7.  10-year follow-up of intensive glucose control in type 2 diabetes.

Authors:  Rury R Holman; Sanjoy K Paul; M Angelyn Bethel; David R Matthews; H Andrew W Neil
Journal:  N Engl J Med       Date:  2008-09-10       Impact factor: 91.245

Review 8.  Pathophysiology of prediabetes.

Authors:  Muhammad A Abdul-Ghani; Ralph A DeFronzo
Journal:  Curr Diab Rep       Date:  2009-06       Impact factor: 4.810

9.  Diabetes in Asia.

Authors:  Ambady Ramachandran; Ronald Ching Wan Ma; Chamukuttan Snehalatha
Journal:  Lancet       Date:  2009-10-28       Impact factor: 79.321

10.  Expanding role of the Madras Diabetes Research Foundation - Indian Diabetes Risk Score in clinical practice.

Authors:  Viswanathan Mohan; Viknesh Prabu Anbalagan
Journal:  Indian J Endocrinol Metab       Date:  2013-01
  10 in total
  19 in total

1.  Pharmacovigilance in India: Present Scenario and Future Challenges.

Authors:  V Kalaiselvan; Sushma Srivastava; Abhishank Singh; S K Gupta
Journal:  Drug Saf       Date:  2019-03       Impact factor: 5.606

2.  Treating the Onset of Diabetes Using Probiotics Along with Prebiotic from Pachyrhizus erosus in High-Fat Diet Fed Drosophila melanogaster.

Authors:  Amrita Bhanja; Nibedita Nayak; Sumit Mukherjee; Parag Prakash Sutar; Monalisa Mishra
Journal:  Probiotics Antimicrob Proteins       Date:  2022-06-16       Impact factor: 5.265

3.  Fluoxetine Ecofriendly Nanoemulsion Enhances Wound Healing in Diabetic Rats: In Vivo Efficacy Assessment.

Authors:  Nabil A Alhakamy; Giuseppe Caruso; Anna Privitera; Osama A A Ahmed; Usama A Fahmy; Shadab Md; Gamal A Mohamed; Sabrin R M Ibrahim; Basma G Eid; Ashraf B Abdel-Naim; Filippo Caraci
Journal:  Pharmaceutics       Date:  2022-05-26       Impact factor: 6.525

4.  Study of adverse drug reactions in patients with diabetes attending a tertiary care hospital in New Delhi, India.

Authors:  Abhishank Singh; Shridhar Dwivedi
Journal:  Indian J Med Res       Date:  2017-02       Impact factor: 2.375

5.  Use of Dental Practices for the Identification of Adults With Undiagnosed Type 2 Diabetes Mellitus or Nondiabetic Hyperglycemia: Protocol for a Systematic Review.

Authors:  Zehra Yonel; Praveen Sharma; Laura J Gray
Journal:  JMIR Res Protoc       Date:  2018-11-19

6.  Magnesium Deficiency Questionnaire: A New Non-Invasive Magnesium Deficiency Screening Tool Developed Using Real-World Data from Four Observational Studies.

Authors:  Svetlana Orlova; Galina Dikke; Gisele Pickering; Sofya Konchits; Kirill Starostin; Alina Bevz
Journal:  Nutrients       Date:  2020-07-11       Impact factor: 5.717

7.  Diet-induced prediabetes: effects of exercise treatment on risk factors for cardiovascular complications.

Authors:  Mluleki Luvuno; Andile Khathi; Musa V Mabandla
Journal:  Nutr Metab (Lond)       Date:  2021-04-22       Impact factor: 4.169

8.  Recognition of diabetes and sociodemographic predictors: results of a cross-sectional nationwide population-based survey in Singapore.

Authors:  Kumarasan Roystonn; Jue Hua Lau; P V AshaRani; Fiona Devi Siva Kumar; Peizhi Wang; Chee Fang Sum; Eng Sing Lee; Siow Ann Chong; Mythily Subramaniam
Journal:  BMJ Open       Date:  2022-03-01       Impact factor: 2.692

Review 9.  Safety and Mode of Action of Diabetes Medications in comparison with 5-Aminolevulinic Acid (5-ALA).

Authors:  Peter R Rehani; Hanaa Iftikhar; Motowo Nakajima; Tohru Tanaka; Zaid Jabbar; Riyadh N Rehani
Journal:  J Diabetes Res       Date:  2019-11-06       Impact factor: 4.011

10.  A Hybrid Approach for Modeling Type 2 Diabetes Mellitus Progression.

Authors:  Sajida Perveen; Muhammad Shahbaz; Muhammad Sajjad Ansari; Karim Keshavjee; Aziz Guergachi
Journal:  Front Genet       Date:  2020-01-07       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.